Dr. Steven Charles Dilsaver, MD

Dr. Dilsaver practices at Modivcare Solutions in Atlanta, Georgia.

Dr. Dilsaver's NPI, 1154463941, was assigned on February 12, 2007. Dr. Dilsaver graduated from University of California, San Diego School of Medicine in 1980. Dr. Dilsaver holds California license G87120.

Dr. Dilsaver's primary practice is Modivcare Solutions, at 1275 Peachtree NE St, Atlanta, GA 30309 in Fulton County. The practice phone is (800) 486-7647.

Dr. Dilsaver's primary practice is Modivcare Solutions in Atlanta, Georgia. The medical group on file is Desert Care Clinic. Dmand AI also links Dr. Dilsaver to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dilsaver practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Dilsaver's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Dilsaver is licensed in California.

CMS data shows 183 Medicare services from Dr. Dilsaver across 3 procedure codes in 2024, for 56 Medicare patients. Medicare paid $17,635 for them. Every service was in an office.

CMS counts 56 Medicare patients who saw Dr. Dilsaver in 2024. The largest group is 75 to 84, with 20 patients. 75% of them have anxiety, and 75% have depression. 59% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dilsaver's median patient age at 63, with 65% women.

In 2024, Dr. Dilsaver wrote 737 Medicare Part D claims for 80 patients. 84% of them were for generic drugs. CMS names the drug for 603 of them, across 25 drugs with 11 or more claims each, at $299,107 in total drug cost. In 2023, CMS named 761 claims across 24 drugs.

Dr. Dilsaver accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dilsaver as offering telehealth. CMS counts 12 procedures of removal of nail tissue by Dr. Dilsaver, more than 59% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Dilsaver, published from 2010 to 2019. The most frequent topics are Norway, Attention Deficit Disorder with Hyperactivity and Bipolar Disorder. Dr. Dilsaver has published most often in Psychiatry Investig.

CMS Open Payments shows 36 general payments to Dr. Dilsaver from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Allergan Inc. paid the most, $173.

Dr. Dilsaver graduated from University of California, San Diego School of Medicine in 1980.